104 related articles for article (PubMed ID: 171663)
1. Comparison between growth characteristics of an Epstein--Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro.
Steinitz M; Klein G
Proc Natl Acad Sci U S A; 1975 Sep; 72(9):3518-20. PubMed ID: 171663
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus type 1 infection of isogenic Epstein-Barr virus genome-negative and -positive Burkitt's lymphoma-derived cell lines.
Leinbach SS; Summers WC
J Virol; 1979 Apr; 30(1):248-54. PubMed ID: 225521
[TBL] [Abstract][Full Text] [Related]
3. Oncogene expression in isogenic, EBV-positive and -negative Burkitt lymphoma cell lines.
Glazer PM; Summers WC
Intervirology; 1985; 23(2):82-9. PubMed ID: 2984143
[TBL] [Abstract][Full Text] [Related]
4. Cell-density-dependence for growth in agarose of two human lymphoma lines and its decrease after Epstein-Barr virus conversion.
Montagnier L; Gruest J
Int J Cancer; 1979 Jan; 23(1):71-5. PubMed ID: 215564
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-induced increase in the concanavalin-A receptor density of established EBV-negative lymphoma lines in vitro.
Siegert W; Mönch T; Valet G
Exp Hematol; 1980 Nov; 8(10):1173-82. PubMed ID: 6262102
[TBL] [Abstract][Full Text] [Related]
6. Possible DNA-RNA tumor virus interaction in human lymphomas: expression of retroviral proteins in Ramos lymphoma lines is enhanced after conversion with Epstein-Barr virus.
Lasky RD; Troy FA
Proc Natl Acad Sci U S A; 1984 Jan; 81(1):33-7. PubMed ID: 6320170
[TBL] [Abstract][Full Text] [Related]
7. Changes in the protein composition of Epstein-Barr Virus-negative lymphoma cells after EBV-conversion.
Siegert W; Mönch T
Anticancer Res; 1983; 3(1):11-6. PubMed ID: 6299173
[TBL] [Abstract][Full Text] [Related]
8. Post-transcriptional mechanisms of deregulation of MYC following conversion of a human B cell line by Epstein-Barr virus.
Lacy J; Summers WP; Summers WC
EMBO J; 1989 Jul; 8(7):1973-80. PubMed ID: 2551670
[TBL] [Abstract][Full Text] [Related]
9. Interactions between Epstein-Barr virus (EBV) and human cell lines: growth and EBV induction.
Takimoto T; Iwawaki J; Tanaka S; Umeda R
ORL J Otorhinolaryngol Relat Spec; 1990; 52(1):40-6. PubMed ID: 2154734
[TBL] [Abstract][Full Text] [Related]
10. Conversion of the lymphoma line "BJAB" by Epstein-Barr virus into phenotypically altered sublines is accompanied by increased c-myc mRNA levels.
Wennborg A; Aman P; Saranath D; Pear W; Sümegi J; Klein G
Int J Cancer; 1987 Aug; 40(2):202-6. PubMed ID: 3038758
[TBL] [Abstract][Full Text] [Related]
11. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
Fresen KO; zur Hausen H
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
[TBL] [Abstract][Full Text] [Related]
12. Amplification and deregulation of MYC following Epstein-Barr virus infection of a human B-cell line.
Lacy J; Summers WP; Watson M; Glazer PM; Summers WC
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5838-42. PubMed ID: 3039510
[TBL] [Abstract][Full Text] [Related]
13. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG
Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
[TBL] [Abstract][Full Text] [Related]
14. Cell surface glycoprotein patterns of two EBV-negative lines and their EBV converted sublines.
Koide N; Wells A; Klein G; Ernberg I
Intervirology; 1981; 16(3):142-8. PubMed ID: 6277822
[TBL] [Abstract][Full Text] [Related]
15. Differential cytotoxicity of tumour promoter TPA for EBV-negative human lymphoma cell lines and their EBV-converted sublines.
Béchet JM; Guétard D
Int J Cancer; 1983 Jul; 32(1):61-5. PubMed ID: 6305854
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus (EBV) and human hematopoietic cell lines: a review.
Tatsumi E
Hum Cell; 1992 Mar; 5(1):79-86. PubMed ID: 1329932
[TBL] [Abstract][Full Text] [Related]
17. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.
Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D
Intervirology; 1975; 5(6):319-34. PubMed ID: 181343
[TBL] [Abstract][Full Text] [Related]
18. Retrovirus-like particles in EBV-negative Burkitt's lymphoma cell line but not in EBV-DNA-positive lines from patients with ataxia telangiectasia and Down's syndrome.
Kotler M; Balabanova H; Friedmann A; Becker Y
Br J Cancer; 1979 Apr; 39(4):414-21. PubMed ID: 220999
[TBL] [Abstract][Full Text] [Related]
19. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.
Menezes J; Leibold W; Klein G; Clements G
Biomedicine; 1975 Jul; 22(4):276-84. PubMed ID: 179629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
